Browse

Introduction: In Europe the prevalence of Parkinson’s disease has been estimated between 65.6 per100 000 inhabitants and 12 500 per100 000 inhabitants. It is one of the most widespread diseases affecting, of course, the patients` quality of life. The aim of our research was to determine the level of quality of life and depression as well as their mutual relationship in patients with Parkinson`s disease, and further to compare the variables monitored with a control group. Method: We adopted the quantitative resea...